Guyasuta Investment Advisors Inc Abb Vie Inc. Transaction History

Guyasuta Investment Advisors Inc

$1.46 Billion
Q1 2024

A detailed history of Guyasuta Investment Advisors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Guyasuta Investment Advisors Inc holds 31,256 shares of ABBV stock, worth $5.19 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

31,256

Previous 31,256 -0.0%

Holding current value

$5.19 Million

Previous $4.84 Million 17.51%

% of portfolio

0.39%

Previous 0.36%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $172,688 - $194,487	-1,255 Reduced 3.86%	31,256 $4.84 Million
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $103,398 - $119,699	774 Added 2.44%	32,511 $4.85 Million
Q2 2023 Jul 17, 2023	SELL	$132.51 - $164.9 $23,454 - $29,187	-177 Reduced 0.55%	31,737 $4.28 Million
Q1 2023 Apr 28, 2023	SELL	$144.61 - $166.54 $22,125 - $25,480	-153 Reduced 0.48%	31,914 $5.09 Million
Q4 2022 Jan 30, 2023	BUY	$138.31 - $165.87 $19,225 - $23,055	139 Added 0.44%	32,067 $5.19 Million

Q3 2022 Oct 25, 2022	BUY	$134.21 - $153.93 $12,078 - $13,853	90 Added 0.28%	31,928 $4.29 Million
Q2 2022 Jul 21, 2022	SELL	$137.62 - $174.96 $722,092 - $918,015	-5,247 Reduced 14.15%	31,838 $4.88 Million
Q1 2022 May 03, 2022	SELL	$131.98 - $163.75 $104,132 - $129,198	-789 Reduced 2.08%	37,085 $6.01 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $203,436 - $230,931	1,912 Added 5.32%	37,874 $4.09 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $166,757 - $185,777	1,585 Added 4.61%	35,962 $4.05 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $45,318 - $49,890	443 Added 1.31%	34,377 $3.72 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $33,161 - $44,772	412 Added 1.23%	33,934 $3.64 Million
Q3 2020 Oct 28, 2020	BUY	$85.91 - $100.83 $256,441 - $300,977	2,985 Added 9.78%	33,522 $2.94 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $502,364 - $672,238	6,847 Added 28.9%	30,537 $3 Million
Q1 2020 Apr 28, 2020	BUY	$64.5 - $97.79 $100,362 - $152,161	1,556 Added 7.03%	23,690 $1.81 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $34,983 - $43,771	-485 Reduced 2.14%	22,134 $1.96 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $74,969 - $92,457	-963 Reduced 4.08%	22,619 $2.09 Million
Q3 2018 Nov 08, 2018	SELL	$88.91 - $98.84 $46,677 - $51,891	-525 Reduced 2.18%	23,582 $2.23 Million
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $57,548 - $68,093	641 Added 2.73%	24,107 $2.23 Million
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $132,218 - $177,052	1,437 Added 6.52%	23,466 $2.22 Million
Q2 2017 Aug 09, 2017	BUY	N/A	22,029	22,029 $1.6 Million

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guyasuta Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guyasuta Investment Advisors Inc with notifications on news.

Account

Guyasuta Investment Advisors Inc Abb Vie Inc. Transaction History